A simulation study on the dosimetric benefit of real-time motion compensation in spot-scanning proton therapy for prostate

被引:5
|
作者
Fujii, Yusuke [1 ]
Matsuura, Taeko [1 ,2 ,3 ]
Takao, Seishin [1 ,2 ,3 ]
Matsuzaki, Yuka [1 ]
Fujii, Takaaki [1 ]
Miyamoto, Naoki [4 ]
Umegaki, Kikuo [1 ,2 ,3 ]
Nishioka, Kentaro [1 ,5 ]
Shimizu, Shinichi [1 ,2 ,5 ]
Shirato, Hiroki [1 ,2 ,5 ]
机构
[1] Hokkaido Univ Hosp, Proton Beam Therapy Ctr, Kita 14 Nishi 5, Sapporo, Hokkaido 0608648, Japan
[2] Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Quantum Med Sci & Engn, Kita 14 Nishi 5, Sapporo, Hokkaido 0608648, Japan
[3] Hokkaido Univ, Div Quantum Sci & Engn, Fac Engn, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan
[4] Hokkaido Univ Hosp, Dept Med Phys, Kita 14 Nishi 5, Sapporo, Hokkaido 0608648, Japan
[5] Hokkaido Univ Hosp, Dept Radiat Oncol, Kita 15 Nishi 7, Sapporo, Hokkaido 0608638, Japan
关键词
gated radiotherapy; spot scanning; moving target; prostate cancer; RADIOTHERAPY;
D O I
10.1093/jrr/rrx020
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
For proton spot scanning, use of a real-time-image gating technique incorporating an implanted marker and dual fluoroscopy facilitates mitigation of the dose distribution deterioration caused by interplay effects. This study explored the advantages of using a real-time-image gating technique, with a focus on prostate cancer. Two patient-positioning methods using fiducial markers were compared: (i) patient positioning only before beam delivery, and (ii) patient positioning both before and during beam delivery using a real-time-gating technique. For each scenario, dose distributions were simulated using the CT images of nine prostate cancer patients. Treatment plans were generated using a single-field proton beam with 3-mm and 6-mm lateral margins. During beam delivery, the prostate was assumed to move by 5 mm in four directions that were perpendicular to the beam direction at one of three separate timings (i.e. after the completion of the first, second and third quartiles of the total delivery of spot irradiation). Using a 3-mm margin and second quartile motion timing, the averaged values for Delta D-99, Delta D-95, Delta D-5 and D5-95 were 5.1%, 3.3%, 3.6% and 9.0%, respectively, for Scenario (i) and 2.1%, 1.5%, 0.5% and 4.1%, respectively, for Scenario (ii). The margin expansion from 3 mm to 6 mm reduced the size of Delta D-99, Delta D-95, Delta D-5 and D5-95 only with Scenario (i). These results indicate that patient positioning during beam delivery is an effective way to obtain better target coverage and uniformity while reducing the target margin when the prostate moves during irradiation.
引用
收藏
页码:591 / 597
页数:7
相关论文
共 50 条
  • [41] Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study
    Liu, Gang
    Li, Xiaoqiang
    Qin, An
    Zheng, Weili
    Yan, Di
    Zhang, Sheng
    Stevens, Craig
    Kabolizadeh, Peyman
    Ding, Xuanfeng
    [J]. RADIATION ONCOLOGY, 2020, 15 (01)
  • [42] Linear Energy Transfer Incorporated Spot-Scanning Proton Arc Therapy Optimization: A Feasibility Study
    Li, Xiaoqiang
    Ding, Xuanfeng
    Zheng, Weili
    Liu, Gang
    Janssens, Guillaume
    Souris, Kevin
    Barragan-Montero, Ana M. M.
    Yan, Di
    Stevens, Craig
    Kabolizadeh, Peyman
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] Interplay Effect in Spot-Scanning Proton Therapy with Rescanning, Breath Holding, and Gating: A Phantom Study
    Belikhin, Mikhail
    Shemyakov, Alexander
    Ivanov, Dmitry
    Zavestovskaya, Irina
    [J]. APPLIED SCIENCES-BASEL, 2024, 14 (18):
  • [44] Is Spot-Scanning Proton Beam Therapy Ready for the Single Target Brain Stereotactic Radiosurgery? A Dosimetric Comparison Study Among VMAT, SPArc and IMPT
    Chang, S.
    Liu, G.
    Chinnaiyan, P.
    Zhao, L.
    Zheng, W.
    Yan, D.
    Grills, I.
    Stevens, C.
    Kabolizadeh, P.
    Li, X.
    Ding, X.
    [J]. MEDICAL PHYSICS, 2020, 47 (06) : E468 - E468
  • [45] Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study
    Gang Liu
    Xiaoqiang Li
    An Qin
    Weili Zheng
    Di Yan
    Sheng Zhang
    Craig Stevens
    Peyman Kabolizadeh
    Xuanfeng Ding
    [J]. Radiation Oncology, 15
  • [46] Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer
    Pugh, Thomas J.
    Munsell, Mark F.
    Choi, Seungtaek
    Quyhn Nhu Nguyen
    Mathai, Benson
    Zhu, X. Ron
    Sahoo, Narayan
    Gillin, Michael
    Johnson, Jennifer L.
    Amos, Richard A.
    Dong, Lei
    Mahmood, Usama
    Kuban, Deborah A.
    Frank, Steven J.
    Hoffman, Karen E.
    McGuire, Sean E.
    Lee, Andrew K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (05): : 946 - 953
  • [47] Clinical implementation of respiratory-gated spot-scanning proton therapy: An efficiency analysis of active motion management
    Gelover, Edgar
    Deisher, Amanda J.
    Herman, Michael G.
    Johnson, Jedediah E.
    Kruse, Jon J.
    Tryggestad, Erik J.
    [J]. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2019, 20 (05): : 99 - 108
  • [48] What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy
    Toramatsu, Chie
    Katoh, Norio
    Shimizu, Shinichi
    Nihongi, Hideaki
    Matsuura, Taeko
    Takao, Seishin
    Miyamoto, Naoki
    Suzuki, Ryusuke
    Sutherland, Kenneth
    Kinoshita, Rumiko
    Onimaru, Rikiya
    Ishikawa, Masayori
    Umegaki, Kikuo
    Shirato, Hiroki
    [J]. RADIATION ONCOLOGY, 2013, 8
  • [49] Dosimetric feasibility of real-time MRI-guided proton therapy
    Moteabbed, M.
    Schuemann, J.
    Paganetti, H.
    [J]. MEDICAL PHYSICS, 2014, 41 (11)
  • [50] Real-time motion-including dose reconstruction for pencil beam scanning proton therapy
    Skouboe, S.
    Poulsen, P. R.
    Ravkilde, T.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S28 - S29